Abeona Therapeutics Inc (NAS:ABEO)
$ 5.38 -0.11 (-2.01%) Market Cap: 307.94 Mil Enterprise Value: 179.55 Mil PE Ratio: 0 PB Ratio: 2.40 GF Score: 30/100

Abeona Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 16, 2026 / 03:30PM GMT
Release Date Price: $5.39 (-1.73%)
Vishwas Seshadri
Abeona Therapeutics Inc - President, Chief Executive Officer, Director

No, great, very thoughtful.

And I have some updates.

Unidentified Company Representative

I want to talk to you about -- we'll chat later about other stuff.

Vishwas Seshadri
Abeona Therapeutics Inc - President, Chief Executive Officer, Director

Yeah.

Unidentified Company Representative

Great. Thank you all for coming to the annual Morgan Stanley Healthcare Conference. My name is Rak Bion. I am the head of West Coast Healthcare Investment Banking for Morgan Stanley. I have the pleasure of hosting the Abiona Therapeutics Management Team today. We'll go through a few questions, but recognizing that this is the first time Abiona is at our conference, would love to maybe start with a round of introductions.

Vishwas Seshadri
Abeona Therapeutics Inc - President, Chief Executive Officer, Director

Thank you so much for having us, Rak. I'm Vishesh

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot